Real-World Evaluation of Vildagliptin Plus Metformin in Elderly Patients with Type 2 Diabetes: Results from a One-Year Observational Study in Russia

被引:0
|
作者
Zilov, Alexey
Emirova, Aida
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2369-PUB
引用
收藏
页码:A595 / A595
页数:1
相关论文
共 50 条
  • [31] Effectiveness and Tolerability of Vildagliptin plus Metformin Compared with Other Oral Dual Antidiabetes Agents in Different Baseline BMI Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Jin, Hui
    Han, Ying
    Chen, Lixian
    Hu, Daqing
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Zang, Li
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [32] Vildagliptin with Metformin: Results from a 1-Year Observational Study in Real-Life Russian Clinical Settings
    Zilov, Alexey
    Emirova, Aida
    DIABETES, 2015, 64 : A333 - A333
  • [33] One-Year Follow-up from Basal Insulin Initiation in Type 2 Diabetes Patients with Reduced Renal Function: Real-World Data Analyses
    Mo, Daojun
    Li, Qian
    Bae, Jay P.
    Edgell, Eric T.
    Engelman, William A.
    Hoogwerf, Byron J.
    DIABETES, 2015, 64 : A155 - A155
  • [34] One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment
    Kothny, W.
    Shao, Q.
    Groop, P. -H.
    Lukashevich, V.
    DIABETES OBESITY & METABOLISM, 2012, 14 (11): : 1032 - 1039
  • [35] Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study
    Guo, Lixin
    Wang, Jing
    Li, Li
    Yuan, Lin
    Chen, Sheng
    Wang, Hui
    Li, Tonghuan
    Qi, Lin
    Yang, Hong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 219
  • [36] One-Year Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation: Placing Real-World Results Into Perspective
    Miyares, Marta A.
    JAMA INTERNAL MEDICINE, 2015, 175 (07) : 1242 - 1243
  • [37] Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States
    Mahabaleshwarkar, Rohan
    DeSantis, Andrea
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 172
  • [38] The effectiveness of dapagliflozin and lixisenatide in managing Type 2 diabetes: a real-world observational study
    Duffy, A.
    Smith, C.
    Harrow, C.
    McGowan, N.
    McIntyre, M.
    So, B.
    Jones, C.
    Gonzalez, N.
    DIABETIC MEDICINE, 2016, 33 : 166 - 166
  • [39] Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study
    Rudofsky, Gottfried
    Catarig, Andrei-Mircea
    Favre, Lucie
    Grau, Katrine
    Hafliger, Susan
    Thomann, Robert
    Schultes, Bernd
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [40] Glycemic Control in Insulinized Type 2 Diabetes Patients in China: One-Year Results from IDMPS
    Ji, Linong
    Jia, Weiping
    Weng, Jianping
    DIABETES, 2009, 58 : A525 - A525